New Data Rescues Zymar Patent, Allergan Tells Fed. Circ.
Allergan Inc. told a Federal Circuit panel on Thursday that a Delaware federal judge failed to give adequate weight to new scientific evidence supporting its pinkeye treatment patent in its infringement...To view the full article, register now.
Already a subscriber? Click here to view full article